Related Experiment Videos
MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells
John Romashko1, Stuart Horowitz, William R Franek
1Department of Surgery, North Shore University Hospital, New York University School of Medicine, Manhasset, NY, USA.
Free Radical Biology & Medicine
|October 15, 2003
Summary
Prolonged hyperoxia induces programmed cell death called oncosis in lung epithelial cells, involving AP-1, JNK, and p38 MAPK pathways. These pathways are also involved in oxidative apoptosis, suggesting shared targets for lung injury treatment.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Molecular Mechanisms of Disease
Background:
- Cell injury and death in pulmonary epithelium are key in acute lung injury pathogenesis.
- Hyperoxia exposure can lead to significant lung tissue damage.
Purpose of the Study:
- To investigate the molecular mechanisms driving cell death in lung epithelium under hyperoxia.
- To differentiate between apoptotic and oncotic cell death pathways induced by hyperoxia.
Main Methods:
- Exposure of MLE-12 cells to 95% oxygen (hyperoxia).
- Assay for caspase-3 activity and phosphatidylserine translocation to distinguish apoptosis from oncosis.
- Analysis of transcription factor AP-1 and mitogen-activated protein kinase (MAPK) pathways (p38 and JNK).
- Inhibition of AP-1, p38, and JNK pathways to assess their role in cell survival.
Main Results:
- Hyperoxia induced cell death characterized by swelling and mitochondrial dysfunction, consistent with oncosis, not apoptosis.
- Sustained activation of AP-1, p38, and JNK was observed in hyperoxia-exposed cells.
- Inhibiting AP-1, p38, or JNK significantly enhanced MLE-12 cell survival during hyperoxia.
- Oxidative apoptosis induced by hydrogen peroxide also involved AP-1, JNK, and p38 pathways.
Conclusions:
- Hyperoxia triggers a programmed oncosis in lung epithelial cells mediated by AP-1, JNK, and p38 MAPK.
- Despite different downstream events, both hyperoxic oncosis and oxidative apoptosis share upstream signaling pathways.
- Targeting these shared upstream pathways (AP-1, JNK, p38) may offer therapeutic strategies for hyperoxic lung injury.